Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Mar/19/2021 81 18
Amodiaquine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/12/2021 6 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/08/2021 25 7
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Mar/08/2021 40 43
Methylprednisolone Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/23/2021 34 4
Mefloquine hydrochloride Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/15/2021 8 0
Ruxolitinib Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/06/2021 8 0
Chlorpromazine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Dec/10/2020 3 0
Mitoxantrone Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/04/2020 2 0
Imatinib Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Sep/21/2020 4 0